Cytostatic drug treatment causes seeding of gene promoter methylation
Authors:
Open Access
- 1 March 2007
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 43 (5) , 947-954
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aberrant methylation patterns of theRassf1a gene in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amineMolecular Carcinogenesis, 2005
- Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarkerDrug Resistance Updates, 2004
- The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer PatientsClinical Cancer Research, 2004
- Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer CellsCancer Research, 2004
- Role of the Promoter in Maintaining Transcriptionally Active Chromatin Structure and DNA Methylation Patterns In VivoMolecular and Cellular Biology, 2003
- Aberrant DNA Methylation in Ovarian CancerAnnals of the New York Academy of Sciences, 2003
- Periodic DNA Methylation in Maize Nucleosomes and Demethylation by Environmental StressJournal of Biological Chemistry, 2002
- Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cellsOncogene, 2002
- Epigenetic variation in Arabidopsis disease resistanceGenes & Development, 2002
- HPRT: GENE STRUCTURE, EXPRESSION, AND MUTATIONAnnual Review of Genetics, 1985